We recently compiled a list of the Top 8 AI News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

The stock is up 9.4% since reporting and currently trades at $169.90. Is now the time to buy Quest ... Access our full analysis of the earnings results here, it’s free. Founded in 2012, Guardant ...

Provides long-term outlook beyond 2025: Revenues expected to grow at 4-5% compound annual growth rate (CAGR); adjusted diluted earnings per share (EPS) expected to grow at 7-9% CAGR Reaffirms guidance ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including ...

DGX outperforms the industry and the S&P 500 composite's gain in the past year, driven by strong core performance and contributions from acquisitions. Quest Diagnostics Incorporated ( NYSE:DGX ) will ...